Mr. David Preiner reports

MEDIVOLVE WELCOMES VINCENT CHEN AS VP OF CORPORATE DEVELOPMENT

Medivolve Inc. has appointed Vincent Chen, CPA, as vice-president of corporate development.

Mr. Chen is a chartered professional accountant (Canada) with an extensive background in financial reporting, investor relations and corporate development for publicly traded companies. Mr. Chen's experience includes working at PricewaterhouseCoopers LLP (PwC) where he worked within its assurance practice with a focus on emerging technology as well as the precious metals sectors. Most recently, Mr. Chen worked at Yamana Gold Inc., one of Canada's largest precious metal producers, in its corporate reporting segment that included governance, financial disclosures and compliance.

"I am truly excited to bring my experience into the health care technology industry. I firmly believe that my expertise in financial markets and within the field will be incredibly valuable in helping drive shareholder value for Medivolve and our investors," said Mr. Chen. "I want to position and convey Medivolve's strategies to the investment community and to all our key stakeholders in a clear manner that will have a positive impact on the future of our business."

The company will be hosting a corporate update presentation with analysts and investors via live webinar on Thursday, April 7, at 12 p.m. EST. Participants can register and submit questions on-line.

About Medivolve Inc.

Medivolve is a health care technology company that seeks to reinvent the U.S. health care system by leveraging a bespoke telehealth platform, a clinical diagnostic network and a data-driven artificial intelligence framework to improve patient care. The company was born out of the health care crisis, to rethink, relearn and ultimately reimagine a better way for the health care system to operate. Its network of retail collection sites plays an essential role in recovery by giving all Americans access to fast, accurate and inexpensive clinical services when and where they need them. These centres will also play a pivotal role in diagnostic testing, vaccinations and other point-of-care services. The company is building disruptive technologies to make it easier and faster to identify, treat and prevent medical issues. In doing so, it is working to give patients a holistic and empowered view of their personal health.

The company's long-term mission is to permanently fix systemic issues in the nation's fragmented, overly complex and expensive health care system. Medivolve's next growth phase is about pivoting the model and putting the pieces together to build a profitable, software-as-a-service-based (SaaS) health tech company. Medivolve brings data-driven clinical diagnostics, physician recommendations and prescription medications directly to people, all powered by a singular, streamlined technology network. A powerful, singular purpose unites the company's team: harnessing the transformative power of technology to create healthier lives.

Underpinned by a bespoke, AI-driven (artificial intelligence) platform, the company is developing a stealth system that constantly gets smarter, takes the guesswork out of diagnostics and flags critical health issues immediately to deliver an unparalleled level of personalization for each patient. It is determined to push the boundaries of what is possible -- not just for its business and its shareholders, but for physicians and patients, and the future of health care. The company strives to achieve a continuity of care never seen before, a game-changer for its business and patients in the communities the company serves.

We seek Safe Harbor.